HEADER VIRAL PROTEIN 11-SEP-26 38PM TITLE AUSTRALIAN BAT LYSSAVIRUS GLYCOPROTEIN PH DOMAIN IN COMPLEX WITH TITLE 2 BROADLY NEUTRALIZING HUMAN ANTIBODIES A6 AND RVC20 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIBODY RVC20 HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANTIBODY RVC20 LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: ANTIBODY A6 HEAVY CHAIN; COMPND 11 CHAIN: H; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: ANTIBODY A6 LIGHT CHAIN; COMPND 15 CHAIN: L; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: GLYCOPROTEIN; COMPND 19 CHAIN: G; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 13 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 27 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 28 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 29 MOL_ID: 5; SOURCE 30 ORGANISM_SCIENTIFIC: LYSSAVIRUS AUSTRALIS; SOURCE 31 ORGANISM_TAXID: 90961; SOURCE 32 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 33 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 34 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS ABVL, PHD, ANTIBODY, NEUTRALIZING, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR K.XU,Y.XU REVDAT 1 30-SEP-26 38PM 0 JRNL AUTH C.HUAMAN,Y.XU,N.M.LOTT,E.M.SANTORELLA,M.RADER, JRNL AUTH 2 A.M.STRAZZELLA,C.CLOUSE,J.M.KING,M.MELNYK,J.HONG,L.YAN, JRNL AUTH 3 A.C.PASKEY,A.E.LUQUETTE,F.MALAGON,R.Z.CER,K.A.BISHOP-LILLY, JRNL AUTH 4 D.P.PERL,C.C.BRODER,K.XU,B.C.SCHAEFER JRNL TITL PERIPHERAL HUMAN MAB THERAPY YIELDS MODULATION OF JRNL TITL 2 NEUROINFLAMMATION AND LONG-TERM FUNCTIONAL RECOVERY FROM JRNL TITL 3 LYSSAVIRUS INFECTION. JRNL REF EMERG MICROBES INFECT 36987 2026 JRNL REFN ESSN 2222-1751 JRNL PMID 42758862 JRNL DOI 10.1080/22221751.2026.2736987 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, PHENIX, EPU, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.600 REMARK 3 NUMBER OF PARTICLES : 195885 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 38PM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-SEP-26. REMARK 100 THE DEPOSITION ID IS D_1000311670. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : LYSSAVIRUS AUSTRALIS REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.20 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOCONTINUUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 8000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 25000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, L, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY G 179 REMARK 465 GLY G 180 REMARK 465 GLY G 181 REMARK 465 SER G 182 REMARK 465 GLY G 183 REMARK 465 GLY G 184 REMARK 465 GLY G 185 REMARK 465 GLN G 256 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 30 -4.63 72.63 REMARK 500 GLN A 77 145.40 -170.32 REMARK 500 ASP A 99 -4.28 74.57 REMARK 500 PHE A 100 18.59 58.11 REMARK 500 SER B 9 -4.93 66.96 REMARK 500 SER B 10 135.78 -172.32 REMARK 500 ARG B 61 -8.17 73.40 REMARK 500 ALA H 16 -169.46 -121.02 REMARK 500 SER H 54 -7.29 72.18 REMARK 500 SER L 30 -172.18 61.77 REMARK 500 GLN G 244 -3.35 69.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-79039 RELATED DB: EMDB REMARK 900 AUSTRALIAN BAT LYSSAVIRUS GLYCOPROTEIN PH DOMAIN IN COMPLEX WITH REMARK 900 BROADLY NEUTRALIZING HUMAN ANTIBODIES A6 AND RVC20 DBREF 38PM A 1 113 PDB 38PM 38PM 1 113 DBREF 38PM B 1 107 PDB 38PM 38PM 1 107 DBREF 38PM H 1 112 PDB 38PM 38PM 1 112 DBREF 38PM L 1 107 PDB 38PM 38PM 1 107 DBREF 38PM G 27 47 UNP Q9QSP1 GLYCO_ABLVB 46 66 DBREF 38PM G 188 256 UNP Q9QSP1 GLYCO_ABLVB 207 275 SEQADV 38PM GLY G 48 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 179 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 180 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 181 UNP Q9QSP1 LINKER SEQADV 38PM SER G 182 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 183 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 184 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 185 UNP Q9QSP1 LINKER SEQADV 38PM GLY G 186 UNP Q9QSP1 LINKER SEQADV 38PM SER G 187 UNP Q9QSP1 LINKER SEQRES 1 A 124 GLN VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 A 124 PRO SER GLN THR LEU SER LEU THR CYS THR VAL SER GLY SEQRES 3 A 124 GLY SER PHE SER SER GLY SER TYR SER TRP ASN TRP ILE SEQRES 4 A 124 ARG GLN HIS PRO GLY LYS GLY LEU GLU TRP ILE GLY TYR SEQRES 5 A 124 ILE TYR TYR SER GLY SER THR TYR TYR ASN PRO SER LEU SEQRES 6 A 124 LYS SER ARG VAL THR MET SER VAL HIS THR SER LYS ASN SEQRES 7 A 124 GLN PHE SER LEU LYS LEU ASN SER ILE THR ALA ALA ASP SEQRES 8 A 124 THR ALA VAL TYR TYR CYS ALA ARG GLY THR TYR SER ASP SEQRES 9 A 124 PHE TRP SER GLY SER PRO LEU ASP TYR TRP GLY GLN GLY SEQRES 10 A 124 THR LEU VAL THR VAL SER SER SEQRES 1 B 107 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 B 107 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 B 107 GLN GLY ILE SER ASN TYR LEU ALA TRP PHE GLN GLN LYS SEQRES 4 B 107 PRO GLY LYS ALA PRO LYS SER LEU ILE TYR ALA ALA SER SEQRES 5 B 107 SER LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 B 107 GLY SER GLY THR ASP PHE THR LEU THR ILE ASN SER LEU SEQRES 7 B 107 GLN PRO GLU ASP PHE VAL THR TYR PHE CYS GLN GLN TYR SEQRES 8 B 107 ASP THR TYR PRO LEU THR PHE GLY GLY GLY THR LYS VAL SEQRES 9 B 107 GLU ILE LYS SEQRES 1 H 126 GLU VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 H 126 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 H 126 TYR ASP PHE THR ASP PHE TYR VAL HIS TRP VAL ARG GLN SEQRES 4 H 126 ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TRP ILE ASN SEQRES 5 H 126 PRO GLY SER GLY ALA THR ASP TYR ALA GLN LYS PHE GLN SEQRES 6 H 126 GLY ARG VAL THR MET THR ARG ASP THR SER ILE SER THR SEQRES 7 H 126 ALA TYR MET GLU VAL SER ARG LEU ARG SER ASP ASP THR SEQRES 8 H 126 ALA MET TYR TYR CYS ALA ARG PRO ASN ALA PRO ARG TYR SEQRES 9 H 126 MET GLU ARG LEU SER ALA THR PRO SER PHE ASP SER TRP SEQRES 10 H 126 GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 1 L 108 GLU ILE VAL LEU THR GLN SER PRO GLY THR LEU SER LEU SEQRES 2 L 108 SER PRO GLY GLU GLY ALA THR LEU SER CYS ARG ALA SER SEQRES 3 L 108 GLN SER VAL SER SER ILE ASN LEU ALA TRP TYR GLN GLN SEQRES 4 L 108 LYS PRO GLY GLN ALA PRO ARG LEU LEU MET TYR GLY ALA SEQRES 5 L 108 SER THR ARG ALA THR GLY ILE PRO ASP ARG PHE SER GLY SEQRES 6 L 108 SER GLY SER GLY THR ASP PHE THR LEU THR ILE SER ARG SEQRES 7 L 108 LEU GLU SER GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN SEQRES 8 L 108 TYR GLY SER SER PRO LEU THR PHE GLY GLY GLY THR LYS SEQRES 9 L 108 VAL GLU ILE LYS SEQRES 1 G 100 ASN LEU ILE VAL GLU ASP GLU GLY CYS THR SER LEU SER SEQRES 2 G 100 GLY PHE SER TYR MET GLU LEU LYS GLY GLY GLY GLY SER SEQRES 3 G 100 GLY GLY GLY GLY SER SER CYS ASP ILE PHE THR MET SER SEQRES 4 G 100 LYS GLY LYS LYS ALA SER LYS GLY GLY LYS VAL CYS GLY SEQRES 5 G 100 PHE VAL ASP GLU ARG GLY LEU TYR LYS SER LEU LYS GLY SEQRES 6 G 100 ALA CYS LYS LEU LYS LEU CYS GLY ILE SER GLY LEU ARG SEQRES 7 G 100 LEU LEU ASP GLY SER TRP VAL SER ILE GLN ASN HIS GLU SEQRES 8 G 100 GLU VAL LYS TRP CYS SER PRO ASN GLN HELIX 1 AA1 THR A 83 THR A 87 5 5 HELIX 2 AA2 GLN B 79 PHE B 83 5 5 HELIX 3 AA3 ASP H 28 PHE H 32 5 5 HELIX 4 AA4 ARG H 83 THR H 87 5 5 HELIX 5 AA5 MET H 100A THR H 100G 1 7 SHEET 1 AA1 4 GLN A 3 SER A 7 0 SHEET 2 AA1 4 LEU A 18 SER A 25 -1 O THR A 21 N SER A 7 SHEET 3 AA1 4 GLN A 77 LEU A 82 -1 O LEU A 82 N LEU A 18 SHEET 4 AA1 4 VAL A 67 HIS A 72 -1 N THR A 68 O LYS A 81 SHEET 1 AA2 6 LEU A 11 VAL A 12 0 SHEET 2 AA2 6 THR A 107 VAL A 111 1 O THR A 110 N VAL A 12 SHEET 3 AA2 6 ALA A 88 GLY A 95 -1 N TYR A 90 O THR A 107 SHEET 4 AA2 6 SER A 35 GLN A 39 -1 N SER A 35 O GLY A 95 SHEET 5 AA2 6 GLU A 46 ILE A 51 -1 O ILE A 51 N TRP A 35A SHEET 6 AA2 6 THR A 57 TYR A 59 -1 O TYR A 58 N TYR A 50 SHEET 1 AA3 4 LEU A 11 VAL A 12 0 SHEET 2 AA3 4 THR A 107 VAL A 111 1 O THR A 110 N VAL A 12 SHEET 3 AA3 4 ALA A 88 GLY A 95 -1 N TYR A 90 O THR A 107 SHEET 4 AA3 4 LEU A 100F TYR A 102 -1 O TYR A 102 N ARG A 94 SHEET 1 AA4 4 MET B 4 GLN B 6 0 SHEET 2 AA4 4 VAL B 19 ALA B 25 -1 O ARG B 24 N THR B 5 SHEET 3 AA4 4 ASP B 70 ILE B 75 -1 O PHE B 71 N CYS B 23 SHEET 4 AA4 4 PHE B 62 SER B 67 -1 N SER B 65 O THR B 72 SHEET 1 AA5 5 LEU B 11 ALA B 13 0 SHEET 2 AA5 5 THR B 102 ILE B 106 1 O GLU B 105 N ALA B 13 SHEET 3 AA5 5 THR B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA5 5 LEU B 33 GLN B 38 -1 N PHE B 36 O PHE B 87 SHEET 5 AA5 5 LYS B 45 ILE B 48 -1 O ILE B 48 N TRP B 35 SHEET 1 AA6 4 LEU B 11 ALA B 13 0 SHEET 2 AA6 4 THR B 102 ILE B 106 1 O GLU B 105 N ALA B 13 SHEET 3 AA6 4 THR B 85 GLN B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA6 4 THR B 97 PHE B 98 -1 O THR B 97 N GLN B 90 SHEET 1 AA7 4 GLN H 3 GLN H 6 0 SHEET 2 AA7 4 SER H 17 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 AA7 4 THR H 77 SER H 82A-1 O ALA H 78 N CYS H 22 SHEET 4 AA7 4 VAL H 67 ASP H 72 -1 N ASP H 72 O THR H 77 SHEET 1 AA8 6 GLU H 10 LYS H 12 0 SHEET 2 AA8 6 THR H 107 VAL H 111 1 O LEU H 108 N GLU H 10 SHEET 3 AA8 6 ALA H 88 PRO H 95 -1 N TYR H 90 O THR H 107 SHEET 4 AA8 6 VAL H 34 GLN H 39 -1 N VAL H 37 O TYR H 91 SHEET 5 AA8 6 LEU H 45 ASN H 52 -1 O GLU H 46 N ARG H 38 SHEET 6 AA8 6 ALA H 56 TYR H 59 -1 O ALA H 56 N ASN H 52 SHEET 1 AA9 4 GLU H 10 LYS H 12 0 SHEET 2 AA9 4 THR H 107 VAL H 111 1 O LEU H 108 N GLU H 10 SHEET 3 AA9 4 ALA H 88 PRO H 95 -1 N TYR H 90 O THR H 107 SHEET 4 AA9 4 PHE H 100J TRP H 103 -1 O ASP H 101 N ARG H 94 SHEET 1 AB1 4 LEU L 4 GLN L 6 0 SHEET 2 AB1 4 ALA L 19 ALA L 25 -1 O ARG L 24 N THR L 5 SHEET 3 AB1 4 ASP L 70 ILE L 75 -1 O LEU L 73 N LEU L 21 SHEET 4 AB1 4 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 AB2 2 THR L 10 LEU L 13 0 SHEET 2 AB2 2 LYS L 103 ILE L 106 1 O GLU L 105 N LEU L 11 SHEET 1 AB3 4 ARG L 45 TYR L 49 0 SHEET 2 AB3 4 LEU L 33 GLN L 38 -1 N GLN L 37 O ARG L 45 SHEET 3 AB3 4 VAL L 85 GLN L 90 -1 O VAL L 85 N GLN L 38 SHEET 4 AB3 4 PHE L 98 GLY L 99 -1 O GLY L 99 N CYS L 88 SHEET 1 AB4 4 SER G 37 GLU G 45 0 SHEET 2 AB4 4 THR G 193 SER G 201 -1 O LYS G 199 N SER G 39 SHEET 3 AB4 4 VAL G 206 VAL G 210 -1 O GLY G 208 N ALA G 200 SHEET 4 AB4 4 TYR G 216 SER G 218 -1 O LYS G 217 N PHE G 209 SHEET 1 AB5 3 ALA G 222 LYS G 226 0 SHEET 2 AB5 3 SER G 231 LEU G 235 -1 O GLY G 232 N LEU G 225 SHEET 3 AB5 3 TRP G 240 VAL G 241 -1 O VAL G 241 N LEU G 233 SSBOND 1 CYS A 22 CYS A 92 1555 1555 2.03 SSBOND 2 CYS B 23 CYS B 88 1555 1555 2.04 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 4 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 5 CYS G 35 CYS G 207 1555 1555 2.03 SSBOND 6 CYS G 189 CYS G 228 1555 1555 2.03 SSBOND 7 CYS G 223 CYS G 252 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 160 754 CONECT 754 160 CONECT 1127 1622 CONECT 1622 1127 CONECT 1929 2531 CONECT 2531 1929 CONECT 2919 3426 CONECT 3426 2919 CONECT 3634 3883 CONECT 3754 4044 CONECT 3883 3634 CONECT 4004 4235 CONECT 4044 3754 CONECT 4235 4004 MASTER 142 0 0 5 58 0 0 6 4252 5 14 46 END